Target intelligence / Profile preview

Tubulin protein family (None (commonly referred to as "tubulin" or by specific isoforms such as α-tubulin, β-tubulin))

Target
None (commonly referred to as "tubulin" or by specific isoforms such as α-tubulin, β-tubulin)
Molecular classification
Cytoskeletal protein, GTPase enzyme (for individual tubulins), Structural protein
01

Overview

The Tubulin protein family comprises a group of evolutionarily conserved globular proteins that form heterodimers—primarily α-, β-, γ-, δ-, ε-, and ζ-tubilin—which assemble into linear protofilaments. These protofilaments associate laterally to form cylindrical structures known as microtubules, which are a major component of the eukaryotic cytoskeleton. Microtubes play critical roles in maintaining cell shape, enabling intracellular transport via motor proteins, forming cilia/flagella for motility, and orchestrating chromosome segregation during mitosis/meiosis. Tubulins possess intrinsic GTPase activity essential for their dynamic assembly/disassembly cycles. The disruption of these dynamics underlies both physiological processes like cell division and pathological states such as cancer proliferation—making them key targets for several classes of chemotherapeutic agents that either stabilize or destabilize microtube formation.[1][2][5]

Other names
TubulinsMicrotubule proteinsα-tubulin (TUBA)β-tubulin (TUBB)γ-tubulinδ-tubulinε-tubulinζ-tubulin
02

Mechanism of action

Drugs targeting tubulins generally act by: - Inhibiting tubulin polymerization or depolymerization. - Disrupting microtubule dynamics required for mitosis/cell division. This leads to mitotic arrest and apoptosis in rapidly dividing cells such as cancer cells[1].

03

Biological functions

Cell division/mitosis and meiosis (chromosome segregation)Maintenance of cell shape and structureIntracellular transport (as tracks for motor proteins like kinesin and dynein)Cilia and flagella motility
04

Disease associations

Cancer (targeted by anti-mitotic drugs)Neurodegenerative diseases (microtubule dysfunction implicated in disorders such as Alzheimer's disease)*Note:* While not all sources explicitly mention neurodegeneration, it is widely recognized that microtubule stability is crucial for neuronal function.
05

Safety considerations

Notable safety concerns with targeting tubulins include:Neurotoxicity/peripheral neuropathy due to effects on neuronal microtubules.Myelosuppression/bone marrow toxicity from effects on dividing hematopoietic cells.These side effects limit dosing and duration of many anti-microtubule agents used clinically.*Note:* These concerns are well-documented with approved drugs but not detailed explicitly in search results; included based on established knowledge consistent with context provided about mechanism-of-action drugs.[1]
06

Interacting drugs

Taxanes (e.g., paclitaxel/docetaxel): stabilize microtubules.

4 more in the full profile.

07

Biomarkers

There are no universal biomarkers specific to the entire tubulin family. However:Expression levels of certain β-tubulins can be used as biomarkers for drug resistance or sensitivity in cancer therapy.*Note:* This information is inferred from clinical practice; explicit biomarker lists were not found in the search results.

Beyond the preview

Go deeper on Tubulin protein family (None (commonly referred to as "tubulin" or by specific isoforms such as α-tubulin, β-tubulin)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tubulin protein family (None (commonly referred to as "tubulin" or by specific isoforms such as α-tubulin, β-tubulin)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call